Importantly, elevated ZNF165 mRNA expression correlates significantly with reduced survival time in breast cancer, indicating that expression of this protein may confer an aggressive tumorigenic phenotype (Maxfield et al., 2015). The gene discussed is ZNF165; the disease is breast carcinoma.